Colony Group LLC Vertex Pharmaceuticals Inc Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Colony Group LLC holds 108,145 shares of VRTX stock, worth $43 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

108,145

Previous 110,205 1.87%

Holding current value

$43 Million

Previous $38.8 Million 3.03%

% of portfolio

0.56%

Previous 0.55%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $696,650 - $746,667	-2,060 Reduced 1.87%	108,145 $37.6 Million
Q2 2023 Aug 15, 2023	SELL	$314.42 - $351.91 $704,615 - $788,630	-2,241 Reduced 1.99%	110,205 $38.8 Million
Q1 2023 May 16, 2023	BUY	$283.23 - $323.1 $5.23 Million - $5.96 Million	18,451 Added 19.63%	112,446 $35.4 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $2.22 Million - $2.5 Million	7,769 Added 9.01%	93,995 $27.1 Million
Q3 2022 Nov 15, 2022	BUY	$273.83 - $305.53 $3.39 Million - $3.78 Million	12,368 Added 16.75%	86,226 $25 Million
Q2 2022 Aug 16, 2022	BUY	$234.96 - $292.55 $2.18 Million - $2.71 Million	9,273 Added 14.36%	73,858 $20.8 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $14.3 Million - $16.9 Million	64,585 New	64,585 $16.9 Million
Q1 2021 May 21, 2021	SELL	$207.02 - $241.31 $294,175 - $342,901	-1,421 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $203,283 - $271,120	-982 Reduced 40.87%	1,421 $336,000
Q3 2020 Nov 17, 2020	SELL	$255.65 - $303.1 $14,060 - $16,670	-55 Reduced 2.24%	2,403 $654,000
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $4,058 - $5,324	-18 Reduced 0.73%	2,458 $714,000
Q1 2020 May 18, 2020	SELL	$199.77 - $247.81 $37,756 - $46,836	-189 Reduced 7.09%	2,476 $589,000
Q4 2019 Feb 18, 2020	BUY	$166.71 - $223.91 $1,166 - $1,567	7 Added 0.26%	2,665 $584,000
Q3 2019 Nov 26, 2019	SELL	$166.23 - $187.09 $8,976 - $10,102	-54 Reduced 1.99%	2,658 $450,000
Q2 2019 Aug 19, 2019	SELL	$164.61 - $190.37 $493 - $571	-3 Reduced 0.11%	2,712 $497,000
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $444,526 - $528,610	2,715 New	2,715 $499,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account